ESMO Immuno-Oncology Poster: Hubro Therapeutics QSC204718 (Vaccine Study)
13 December 2022
Overview
Download Quotient Sciences poster on 'A Phase I Study of the Cancer-specific Vaccine FMPV-1 in Healthy Male Subjects to Assess Safety and Immune Response'.